Trials / Conditions / Neoplasms, Pulmonary

Neoplasms, Pulmonary

10 registered clinical trials studyying Neoplasms, Pulmonary — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Precision Lung Cancer Survivorship Care Intervention NCT05857995	Jerod L Stapleton, PhD	N/A
Completed	Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare® NCT05011890	UNC Lineberger Comprehensive Cancer Center	N/A
Active Not Recruiting	Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation NCT04699188	Novartis Pharmaceuticals	Phase 1 / Phase 2
Completed	Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung NCT02410603	Mayo Clinic	—
Terminated	MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s) NCT02673021	Mayo Clinic	N/A
Terminated	Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma NCT02549638	Mayo Clinic	—
Completed	A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System NCT02370303	Mayo Clinic	—
Completed	The Need of Fiberoptic Bronchoscopy for Placing an Endobronchial Blocker NCT02133235	National Taiwan University Hospital	N/A
Completed	A Phase I Study of iPS Cell Generation From Patients With COPD NCT01860898	Mayo Clinic	N/A
Terminated	Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Fa NCT00290017	Point Therapeutics	Phase 3